glp 1 and liver disease Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty (NAFLD) non-alcoholic steatohepatitis (NASH) GLP-1 receptor agonists may protect

You can get them in your inbox by joining my email list at the bottom of this page

Loading models use 100-200 mg daily for 7-10 days under supervision

These concerns kept GIP on the back burner for years while GLP-1 took center stage in drug development

in Wellness How To Prevent Breast Cancer Risk of developing breast cancer can be reduced by eating a healthy diet, moderate exercise and diagnostic testing.

The Clinical Data: CagriSema Crushes Either Peptide Alone Let me give you the numbers that matter, straight from the Phase 3 REDEFINE trials published in the New England Journal of Medicine

We plan conservatively and preserve expression while softening lines